[The efficacy and safety of HAA regimen as induction chemotherapy in 150 newly diagnosed acute myeloid leukemia].

Zhonghua nei ke za zhi [Chinese journal of internal medicine]

Volumn 50, Issue 1, 2011, Pages 48-51

  Song, Yan ping ^a   Tong, Yin ^b   Qian, Wen bin ^b   Mai, Wen yuan ^b   Meng, Hai tao ^b   Qian, Ji jing ^b   Tong, Hong yan ^b   Huang, Jian ^b   Mao, Li ping ^b   Xu, Wei lai ^b   Jin, Jie ^b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACLARUBICIN; ANTINEOPLASTIC AGENT; CYTARABINE; HARRINGTONINE DERIVATIVE; HOMOHARRINGTONINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; DISEASE FREE SURVIVAL; EVALUATION; FEMALE; HUMAN; MALE; MIDDLE AGED; SURVIVAL RATE; TREATMENT OUTCOME;

ACLARUBICIN; ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYTARABINE; DISEASE-FREE SURVIVAL; FEMALE; HARRINGTONINES; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84555189411     PISSN: 05781426     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)